Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘Wrong Type Of Expert’ Advised FTC On Phillip’s Colon Health Claims – CRN

This article was originally published in The Tan Sheet

Executive Summary

FTC’s request that Bayer support claims for Phillip’s Colon Health probiotic supplement with RCTs would set a precedent that would invalidate most structure/function claims, CRN argues, saying FTC’s interpretation of competent and reliable evidence for structure/function claims disregards a wealth of scientific data.

You may also be interested in...

Clinical Trials For Supplement Claims Not An FTC Rule, But A Standard

FTC Bureau of Consumer Protection official Richard Cleland takes on the hot-button issue by explaining that a supplement health or structure/function claim doesn't need support from research with the size and scope of studies looking at the safety and efficacy of a drug ingredient proposed for a certain indication. Supplement ad claims, though, still need competent and reliable scientific evidence as support.

Imposing RCTs For Supplement Claims Would Cause 'Wholesale Change' In Regulation – CRN, CHPA

“The industry would face confusion as to the appropriate substantiation standard for non-disease dietary supplement claims,” say the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a joint amicus brief filed with in Second Circuit. They submitted the brief in support of Quincy’s motion urging the appeals court to dismiss an appeal by FTC and New York of a federal district court’s 2017 dismissal of the federal and state agencies' complaint against Quincy.

Sweeping Change At FTC May Sweep Away RCT Standard For Health Claims

Confirmations by the Senate mark FTC ’s first-ever complete leadership turnover at once and fill out the roster for the first time since President Trump’s election in 2016. The agency has been operating with two commissioners since soon after the election.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts